Table 3.
Comparative Analysis of the Patients with History and Systematic Presentation in Patients with Retinal Vessel Occlusion after SARS-CoV-2 Vaccination
| BNT162b2 | mRNA-1273 | P Value | Chi-square | |
|---|---|---|---|---|
| Risk factors and clinical history | ||||
| Hypertension | 185 (19.98%) | 37 (16.37%) | 0.2636 | 1.249 |
| Diabetes mellitus | 66 (7.10%) | 23 (10.18%) | 0.1573 | 2.003 |
| Hypercholesterolemia | 17 (1.83%) | 4 (1.77%) | 1 | < 0.0001 |
| Intravitreal injections | 43 (4.62%) | 3 (1.33%) | 0.0369 | 4.3531 |
| Stroke | 72 (7.74%) | 22 (9.73%) | 0.3993 | 0.7103 |
| Ischemic heart disease | 23 (2.47%) | 5 (2.21%) | 1 | < 0.0001 |
| Smoking | 68 (7.31%) | 13 (5.75%) | 0.495 | 0.4656 |
| Glaucoma | 33 (3.55%) | 6 (2.65%) | 0.6423 | 0.2157 |
| Arteritis | 11 (1.18%) | 3 (1.33%) | 1 | < 0.0001 |
| Systemic lupus erythematosus | 25 (2.69%) | 1 (0.44%) | 0.1607 | 1.4212 |
| Systemic vasculitis | 24 (2.58%) | 2 (0.88%) | 0.1958 | 1.6738 |
| COVID-19 | 105 (11.29%) | 81 (35.84%) | < 0.001 | 79.207 |
| Systemic presentations | ||||
| Fever | 23 (2.47%) | 9 (3.98%) | 0.3117 | 1.0233 |
| Lymphadenopathy | 6 (0.65%) | 0 | 0.4868 | 0.4836 |
| Malaise | 15 (1.61%) | 2 (0.88%) | 0.6108 | 0.25907 |
| Vomiting | 3 (0.32%) | 0 | 0.8991 | 0.01607 |
| Chest pain | 7 (0.75%) | 2 (0.88%) | 1 | < 0.001 |
| Hypersensitivity | 7 (0.75%) | 0 | 0.4059 | 0.6907 |
COVID-19 = coronavirus disease 2019; SARS-CoV-2 = severe acute respiratory syndrome coronavirus.